Contact
searchSearch
HMP Global
Quiz

Treatment for Nonrad axSpA

Priyam Vora, Associate Editor

12/04/2023
© 2023 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of the Rheumatology and Arthritis Learning Network or HMP Global, their employees, and affiliates. 

Popular Articles

Poll
Assessing Bone Loss in Patients With axSpA
12/05/2024
Rebecca Mashaw
Bone loss has been found to play a significant role in axial spondyloarthritis (axSpA) and regular assessments are recommended. How do you assess bone loss in your patients with axSpA?DXA scanTrabecular bone score Quantitative computed...
Bone loss has been found to play a significant role in axial spondyloarthritis (axSpA) and regular assessments are recommended. How do you assess bone loss in your patients with axSpA?DXA scanTrabecular bone score Quantitative computed...
Bone loss has been found to play...
12/05/2024
Rheumatology & Arthritis
News
No Clear Winner Among PsA Questionnaires
05/16/2024

Rebecca Mashaw, Digital Managing Editor

Rebecca Mashaw, Digital Managing Edit...
Three screening questionnaires were assessed for sensitivity and specificity in identifying undiagnosed psoriatic arthritis among patients with psoriasis.
Three screening questionnaires were assessed for sensitivity and specificity in identifying undiagnosed psoriatic arthritis among patients with psoriasis.
Three screening questionnaires...
05/16/2024
Rheumatology & Arthritis
News
Meta-Analysis Finds Robust Evidence Supporting Upadacitinib for axSpA
09/18/2024
Jolynn Tumolo
Upadacitinib was associated with significant improvements in several key outcomes, including low disease activity.
Upadacitinib was associated with significant improvements in several key outcomes, including low disease activity.
Upadacitinib was associated with...
09/18/2024
Rheumatology & Arthritis
News
Work Productivity Among Patients With PsA Treated With DMARDS
06/19/2024

Jessica Garlewicz, Digital Managing Editor

Jessica Garlewicz, Digital Managing E...
The systematic review and meta-analysis demonstrate that PsA substantially reduces work capacity and leisure activity participation but significant improvements are achieved after 24 weeks of treatment.
The systematic review and meta-analysis demonstrate that PsA substantially reduces work capacity and leisure activity participation but significant improvements are achieved after 24 weeks of treatment.
The systematic review and...
06/19/2024
Rheumatology & Arthritis
News
Disease Burden of Occupations on Patients With PsA
10/18/2024
Jessica Garlewicz
More study is needed to gain understanding of how physical work may influence disease activity among patients with psoriatic arthritis.
More study is needed to gain understanding of how physical work may influence disease activity among patients with psoriatic arthritis.
More study is needed to gain...
10/18/2024
Rheumatology & Arthritis

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1
SPONSORED
Axial Involvement in SpA, Chapter 1
04/26/2022
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses...
04/26/2022
Rheumatology & Arthritis

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use